生物等效性
生物利用度
流变学
体内
药理学
等价(形式语言)
数学
体外
剂型
医学
色谱法
化学
材料科学
生物技术
生物
生物化学
离散数学
复合材料
作者
María Pleguezuelos-Villa,Matilde Merino‐Sanjuán,M. J. Hernández,Amparo Nácher,Daniel Peris,Irene Heras Hidalgo,Lluís Soler,Marta Sallan,Virginia Merino
标识
DOI:10.1016/j.ijpharm.2019.118755
摘要
Determination of bioequivalence remains a challenge in generic topical drug development. To support pharmacokinetic studies, strategies to demonstrate microstructure sameness of the products being compared include in vitro evaluations, such as the comparison of rheological properties, droplet size and in vitro release rates. Nevertheless, defining the appropriate acceptance range to consider equivalence between test and reference formulation is complex. To shed more light into this issue, in vitro release and rheological properties were compared to in vivo bioequivalence data (systemic blood measurements within a clinical trial) after topical application of a single dose. Test and reference formulations of diclofenac diethylamine emulgels were evaluated. While the test formulation met the requirements for equivalence in both the in vivo bioequivalence and in vitro release study, the rheological properties were considered equivalent depending on the criteria used. The 90% confidence interval of the ratios between geometric mean values of both formulations were within the limits of 75-133%, but outside the 90-111% limit under discussion in the scientific community. Altogether these data indicate that differences beyond ±10% between rheological parameters of test and reference formulation might not translate into meaningful release nor bioavailability divergence.
科研通智能强力驱动
Strongly Powered by AbleSci AI